Team Publications 2007


HOURIOUX C
, AIT-GOUGHOULTE M, PATIENT R, FOUQUENET D, ARCANGER F, BRAND D, MARTIN A, ROINGEARD P. Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane. Cell. Microbiol. 2007, 9 : 1014-1027 (Epub 2006, Dec 6).

LAMBELE M, LABROSSE B, ROCH E, MOREAU A, VERRIER B, BARIN F, ROINGEARD P, MAMMANO F, BRAND D. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly. J. Virol. 2007, 81: 125-140 (Epub 2006 Oct 18).

BARIN F, CAZEIN F, LOT F, PILLONEL J, BRUNET S, THIERRY D, DAMOND F, BRUN-VEZINET F, DESENCLOS J-C, SEMAILLE C. Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France : 2003-2006. AIDS 2007, 21, 2351-2353.

ZAMBORLINI A, LEHMANN-CHE J, CLAVE E, GIRON M-L, TOBALY-TAPIERO J, ROINGEARD P, EMILIANI S, TOUBERT A, de THE H, SAIB A. Centrosomal pre-integration latency of HIV-1 in quiescent cells. Retrovirology 2007, 4 : e63 (Epub 2007, September 10).

LEHMANN-CHE J, RENAULT N, GIRON ML, ROINGEARD P, CLAVE E, TOBALY-TAPIERO J, BITTOUN P, TOUBERT A, de THE H, SAIB A. Centrosomal latency of incoming foamy viruses in resting cells. PloS Pathog 2007, 3: 683-689 (e74, Epub 2007, May 25).

BRU T, GALETTO R, PIVER E, COLLIN C, NEGRONI M, PAGES JC. Using RT-prone recombination to promote re-building of complete retroviral vectors from two defective precursors : low efficiency and sequence specificities. J. Virol. Methods 2007, 142: 118-126 (Epub 2007, Mar 1).

PATIENT R, HOURIOUX C, SIZARET P-Y, TRASSARD S, SUREAU C, ROINGEARD P. Hepatitis B subviral envelope particle morphogenesis and intracellular trafficking. J. Virol. 2007, 81: 3842-3851 (Epub 2007, Jan 31).

ALINE F, BRAND D, BOUT D, PIERRE J, FOUQUENET D, VERRIER B, DIMIER-POISSON I. Generation of specific Th1 and CD8+ T-cell responses by immunization with mouse CD8+ dendritic cells loaded with HIV-1 viral lysate or envelope glycoproteins. Microbes Infect. 2007, 9 : 536-543 (Epub 2007, Jan 30).

SAKAROVITCH C, ROUET F, MURPHY G, MINGA A, DABIS F, COSTAGLIOLA D, SALAMON R, PARRY JV, BARIN F. Do tests devised to detect recent infection provide reliable estimates of incidence in Africa ? J. AIDS 2007, 45: 115-122.

SEMAILLE C, BARIN F, CAZEIN F, PILLONEL J, BRAND D, PLANTIER JC, BERNILLON P, LE VU S, PINGET R, DESENCLOS JC. Monitoring the dynamics of the HIV epidemic at a national level using assays for recent infection and serotyping among new HIV diagnoses : experience after two-years in France. J. Infect. Dis. 2007, 196: 377-383.

HOURIOUX C, PATIENT R, MORIN A, BLANCHARD E, MOREAU A, TRASSARD S, GIRAUDEAU B, ROINGEARD P. The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model. Gut 2007, 56: 1302-1308 (Epub 2007 Jan 9).

CHAPEL C, GARCIA C, BARTOSH B, ROINGEARD P, ZITMANN N, COSSET FL, DUBUISSON J, DWEK RA, TREPO C, ZOULIM F, DURANTEL D. Reduction of the infectivity of hepatitis C virus pseudo-particles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors. J. Gen. Virol. 2007, 88: 1133-1143.